Methods for increasing uridine levels with L-nucleosides

Details Methods for increasing uridine levels with L-nucleosides Methods for increasing uridine levels with L-nucleosides

1993-08-13

1996-10-22

Kunz, Gary L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 49, 514 68, 514218, 514533, A61K 3170, A61K 3155, C07D24104, A01N 4362

Patent

active

055676898

ABSTRACT:
A method of increasing intracellular and plasma uridine levels comprising the coadministration or sequential administration of a compound from at least two of the following groups:

REFERENCES:
patent: 4613603 (1986-09-01), Biziere et al.
patent: 4613604 (1986-09-01), Chu et al.
patent: 4874602 (1989-10-01), Calabresi et al.
patent: 4950466 (1990-08-01), Calabresi et al.
patent: 5064946 (1991-11-01), Shaver et al.
patent: 5077280 (1991-12-01), Sommadossi et al.
patent: 5141943 (1992-08-01), Naguib et al.
Jurovcik et al. Nucl. Acids. Res. 3(8):2143-2154, 1976.
The Merck Index, Eleventh Edition. Published by Merck & Co., Inc. Rahway, N.J.: 1989. pp. 504 and 743.
"Interaction Between Uridine and GABA-Mediated Inhibitory Transmission: Studies In Vivo and In Vitro," Guarneri et al., Epilepsia 26(6):666-671 (1985).
"Cytidine and Uridine Requirement of the Brain," Geiger et al., J. Neurochem. 1:93-100 (1956).
"Effects of Uridine and Inosine on Glucose Metabolism in Skeletal Muscle and Activated Lipolysis in Adipose Tissue," Kypson et al., J. Pharmacol. and Exptl. Therapeutics 199(3):565-574 (1976).
"Effect of Cytidine and Uridine on Regeneration of the Liver in Rats Poisoned with Carbon Tetra-cloride," Bushma et al., Bull. Exptl. Biol. Med. 88:1480-1483 (1980).
"Effects of Uridine on the Performance and the Metabolism on Oxygenated and Hypoxic Rabbit Hearts," Kypson et al., J. Mol. Cell. Cardiol. 10:545-565 (1978).
"Anticonvulsant Effects of Uridine: Comparative Analysis of Metrazol and Penicillin Induced Foci," C. A. Roberts, Brain Res. 55:291-308 (1973).
"Vergleichende Untersuchungen zur Hemmung des Adenosinabbaus in vitro durch Dilazep," Pohl et al., Arzheim.-Forsch. (Drug Res.) 24(11a):1901-1905 (1974).
"Zur Toxikologie von Dilazep, einer neuen koronaraktiven Substanz," Abel et al., Arzheim.-Forsch. (Drug Res.) 22(4):667-674 (1972).
"Potentiation by Dilazep of the Negative Inotropic Effect of Adenosine on Guinea-Pig Atria," Fujita et al., Br. J. Pharmac. 68:343-349 (1980).
"Metabolic Effects of Inosine and Uridine in Rabbit Hearts and Rat Skeletal Muscles," Kypson, et al., Biochem. Pharmacol. 26:1585-1591 (1977).
"Enhancement of Fluorouracil Therapy By the Manipulation of Tissue Uridine Pools," Darnowski et al., Pharmac. Ther. 41:381-392 (1989).
"Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzyllacyclouridine," Martin et al., Cancer Chemother. Pharmacol. 24:9-14 (1989).
"Effect of uridine supply on glycogen resynthesis after ischemia in the isolated perfused rat heart," J. Aussedat, Cardiovasc. Res. 17:145-151 (1983).
"Anticonvulsant Activities of .increment.-8 and .increment.-9 Tetrahydrocan-nabinol and Uridine," Dwivedi et al., Toxicol. and App. Pharmacol. 31:452-458 (1975).
"Effects of Nucleosides on Acute Left Ventricular Failure in the Isolated Dog Heart," Buckley et al., Circulation Res. VII:847-857 (Nov. 1959).
"Influence of Certain Nucleosides on Glucose Utilization in Man," Elrick et al., Metabolism X(1):46-55 (Jan. 1962).
"The Relationship Between Uracil Nucleotide Concentrations and Glycogen Synthesis in Hepatocytes From Fed And Fasted Rats," Songu et al., Metabolism 30(2):119-122 (Feb. 1981).
"Dilazep: an inhibitor of adenosine uptake with intrinsic calcium antagonistic properties," Tonini et al., J. Pharm. Pharmacol. 35:434-439 (1983).
"First Report of Management and Outcome of Pregnancies Associated with Hereditary Orotic Aciduria," Bensen et al., Am. J. Med. Gen. 41:426-431 (1991).
"Uridine Incoporation in Normal and Ischaemic Perfused Rat Heart," Aussedat et al., Mol. Phys. 6:247-256 (1984).
"Benzyllacyclouridine Reverses Azidothymidine-Induced Marrow Suppression Without Impairment of Anti-Human Immunodeficiency Virus Activity," Calabresi et al., Blood 76(11):2210-2215 (Dec. 1, 1990).
"Interaction of Uridine with Gaba Binding Sites in Cerebellar Membranes of the Rat," Guarneri et al., Neurochem. Res. 8(12):1537-1545 (1983).
"Phase I and Pharmacokinetic Studies of High-Dose Uridine Intended for Rescue form 5-Fluorouracil Toxicity," Leyva et al., Cancer Res. 44:5928-5933 (Dec. 1984).
"Enhancement of the Antitumor Activity of 5-Fluorouracil by Uridine Rescue," Klubes et al., Pharma. Ther. 41:289-302 (1989).
"Tissue-specific Enhancement of Uridine Utilization and 5-Fluorouracil Therapy in Mice by Benzylacyclouridine," Darnowski et al., Cancer Res. 45:5364-5368 (Nov. 1985).
"Clinical and Pharmacological Study of Orally Administered Uridine," van Groeningen et al., J. Natl. Cancer. Inst. 43*6):437-441 (Mar. 20, 1991).
"High-Dose 5-Fluoroucacil with Delayed Uridine Rescue in Mice," Martin et al., Cancer Res. 42:3964-3970 (Oct. 1982).

Affiliated with

Also associated with

Rating

Methods for increasing uridine levels with L-nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for increasing uridine levels with L-nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for increasing uridine levels with L-nucleosides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2358766